Clinical Trials
30
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (30 trials with phase data)• Click on a phase to view related trials
A Trial of HRS-1893 in Healthy Volunteers
- First Posted Date
- 2025-06-24
- Last Posted Date
- 2025-06-29
- Lead Sponsor
- Atridia Pty Ltd.
- Target Recruit Count
- 20
- Registration Number
- NCT07033455
- Locations
- 🇦🇺
Linear Clinical Research, Nedlands, Western Australia, Australia
A Trial of HRS-5041-103 to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-5041 in Subjects With Metastatic Castration-resistant Prostate Cancer
- Conditions
- Metastatic Castration Resistant Prostate Cancer
- Interventions
- Drug: HRS-5041 Single dose of HRS-5041 orally administered
- First Posted Date
- 2025-02-17
- Last Posted Date
- 2025-07-03
- Lead Sponsor
- Atridia Pty Ltd.
- Target Recruit Count
- 25
- Registration Number
- NCT06830850
- Locations
- 🇦🇺
GenesisCare North Shore (Oncology), Sydney, New South Wales, Australia
🇦🇺Sydney Adventist Hospital, Sydney, New South Wales, Australia
🇦🇺Cancer Research SA, Adelaide, South Australia, Australia
Phase 1 Study to Evaluate PK, Safety, and Tolerability of HRS-5041 in Healthy Caucasian Male Participants
- Conditions
- Prostate Cancer
- Interventions
- Drug: HRS-5041 dose level 1Drug: HRS-5041 dose level 2
- First Posted Date
- 2024-08-19
- Last Posted Date
- 2025-03-18
- Lead Sponsor
- Atridia Pty Ltd.
- Target Recruit Count
- 24
- Registration Number
- NCT06559007
- Locations
- 🇦🇺
Nucleus Network Melbourne, Melbourne, Victoria, Australia
A Trial of SHR-4602 Infusion in Patients With SHR-4602 in Subjects With HER2-expressing or HER2-mutated Locally Advanced or Metastatic Solid Tumors
- Conditions
- HER2-expressing or HER2-mutated Locally or Metastatic Solid Tumors
- Interventions
- First Posted Date
- 2024-08-19
- Last Posted Date
- 2025-01-07
- Lead Sponsor
- Atridia Pty Ltd.
- Target Recruit Count
- 20
- Registration Number
- NCT06560138
- Locations
- 🇦🇺
Scientia Clinical Research Limited, Randwick, New South Wales, Australia
🇦🇺Macquarie University, Sydney, New South Wales, Australia
🇦🇺Icon Cancer Centre South Brisbane, Brisbane, Queensland, Australia
Phase 1 Study of HRS-9231 Safety and Pharmacokinetics in Healthy Caucasians
- Conditions
- MRI
- Interventions
- Drug: HRS-9231or matching placebo
- First Posted Date
- 2024-07-25
- Last Posted Date
- 2024-12-06
- Lead Sponsor
- Atridia Pty Ltd.
- Target Recruit Count
- 20
- Registration Number
- NCT06519981
- Locations
- 🇦🇺
Linear Clinical research, Perth, Western Australia, Australia
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- Next